Medication info

Albitrin Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201501037 · Approved 2015.02.27

This product's status changed to Expired on 2025.02.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, etc.) and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, etc.) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
View approved original text

This medicine is used for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective in conditions caused by excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It can be used to prevent and treat ulcers that may occur after surgery. It helps prevent gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is also used preoperatively to prevent Mendelson's syndrome. Overall, it is effective in protecting the gastrointestinal mucosa and improving inflammation and ulcer symptoms.

How to take

Adult dose

○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients undergoing dialysis or with impaired kidney function. Also, it should not be administered to patients with a history of allergic reactions to this drug or its components, patients with acute porphyria, patients who have undergone upper gastrointestinal tract surgery, pregnant women or women of childbearing potential, premature infants and neonates, and patients on potassium-restricted diets. Caution should be taken when using this drug in patients with liver dysfunction, a history of drug allergy, elderly patients, patients with a history of kidney impairment, and patients taking NSAIDs. Particularly, since it can mask symptoms of stomach cancer, patients with gastric ulcers or patients over middle age who have newly developed or changed dyspepsia symptoms should be screened for malignancy before treatment. Patients with gastric and duodenal ulcers infected with Helicobacter pylori must undergo eradication treatment, and caution is needed for critically ill patients in intensive care and those with hypophosphatemia or swallowing difficulties. Very rarely, severe allergic reactions such as anaphylactic shock may occur while taking this drug; if symptoms appear, immediately stop taking the drug and inform healthcare personnel. Hypersensitivity reactions such as skin rash, urticaria, angioedema, fever, bronchospasm may occur, and withdrawal should be considered if such symptoms occur. Blood tests may rarely show decreased white blood cells or platelets, liver function abnormality, arrhythmia, nausea, vomiting, diarrhea, dizziness, drowsiness, confusion, depression, etc., so consult healthcare personnel if any unusual symptoms arise. Do not use for extended periods, and if no therapeutic effect is observed, consider switching to another medication. Regular blood, liver, and kidney function tests are recommended. Elderly patients or those with chronic lung disease or diabetes may have an increased risk of pneumonia while taking this drug, so caution is needed. If you experience dizziness or drowsiness while taking this drug, avoid driving or operating hazardous machinery. This drug may interact with other medications, so inform healthcare personnel if you are taking other medicines, especially anticoagulants, certain antibiotics, or anticonvulsants. Pregnant or nursing women should not use this medication, and it is not recommended for pediatric use as safety has not been established. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary; if needed, the drug may be removed through blood dialysis. Lastly, this drug may reduce gastric acid secretion, which can promote bacterial growth in the stomach; therefore, regular examinations including eye checks are recommended for long-term users.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 64 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • aplastic anemia
  • pure red cell aplasia
  • acquired autoimmune hemolytic anemia
  • eosinophilia
  • generalized weakness
  • asthenia
  • subcutaneous hemorrhage
  • submucosal hemorrhage
  • fever
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • sense of illness
  • anxiety
  • delirium
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • disturbance of consciousness
  • hepatomegaly muscle spasms
  • gynecomastia
  • excessive milk production
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • blackening of the tongue
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container away from air and moisture, at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.